If there’s been one theme that tells a story about biotech’s situation in 2023, it’s layoffs. The number of staff layoffs across the sector reached such a height that Fierce Biotech began keeping track in March with our Layoff Tracker. We'll discuss the surprising trend and what it might mean for the biotech industry.
And that's not all. Every year, Fierce puts together a special report ranking the top 10 companies by generic drug sales. We discuss those rankings and also the interesting things going on in that sector of the industry.
To learn more about the topics in this episode:
- Fierce Biotech Layoff Tracker: Biogen, Eisai cut workers; Inovio restructures
- The top 10 generic drug makers by 2021 revenue
The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.